Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole with or without cabergoline for uterine myoma regression
IRCT201506205283N12Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of letrozole and cabergoline in Fibromyoma (LM) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Uterine myoma regression. Started Jul 2015; status: completed.
02
Drugs
letrozolecabergoline
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT201506205283N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201506205283N12.